Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-56,328
Closed -$240K 22
2026
Q1
$240K Hold
56,328
﹤0.01% 19
2025
Q4
$305K Sell
56,328
-225,308
-80% -$1.1M ﹤0.01% 20
2025
Q3
$1.13M Hold
281,636
0.03% 14
2025
Q2
$1.93M Hold
281,636
0.04% 13
2025
Q1
$3.58M Hold
281,636
0.09% 12
2024
Q4
$3.85M Buy
281,636
+225,308
+400% +$2.28M 0.09% 12
2024
Q3
$972K Buy
56,328
+1
+0% +$2 0.1% 21
2024
Q2
$88.8K Hold
56,327
0.01% 29
2024
Q1
$161K Hold
56,327
0.01% 31
2023
Q4
$163K Hold
56,327
0.01% 24
2023
Q3
$200K Hold
56,327
0.01% 24
2023
Q2
$369K Hold
56,327
0.01% 23
2023
Q1
$242K Buy
+56,327
New +$346K 0.01% 28

Other funds holding XCUR

Carlyle Group's XCUR Position: Q2 2026 in Review

Carlyle Group sold out of Exicure (XCUR) in Q2 2026, closing a stake of 56,328 shares — an estimated $240K sold.

Carlyle Group first reported a position in XCUR in Q1 2023 and held it in 13 quarters. The position peaked at $3.85M in Q4 2024. 17 funds tracked by Wall St. Rank hold XCUR as of Q2 2026.

  • Carlyle Group reported no remaining Exicure position as of Q2 2026 after selling out during the quarter.
  • Carlyle Group sold 56,328 Exicure shares in Q2 2026, an estimated $240K.
  • Carlyle Group first reported a position in Exicure in Q1 2023 and held it in 13 quarters.
  • Carlyle Group's Exicure position peaked at $3.85M in Q4 2024.
  • 17 funds tracked by Wall St. Rank held Exicure as of Q2 2026.

Based on Carlyle Group's 13F filing for Q2 2026, filed 7 Aug 2026.